health
How a Promising Pancreatic Cancer Drug Loses Its Punch
Pancreatic cancer finally has a drug that buys patients more time—and researchers are already racing to figure out why that benefit fades. Daraxonrasib, cleared in August,...
Pancreatic cancer finally has a drug that buys patients more time—and researchers are already racing to figure out why that benefit fades. Daraxonrasib, cleared in August, roughly doubles median survival time for people with advanced pancreatic cance... [1162 chars]
Read Full ArticleShare this story
Up next
Related Stories
Map Shows States Where Dengue Fever Cases Have Risen After Florida Outbreak
Newsweek
How Marshmallow Root Helps With A Cough
huffpost.com
Why Experts Recommend Using Hand Sanitizer At The Pharmacy
HuffPost
Silent heart threat found in adults under 30 with no known cardiovascular disease
New York Post
Are AI models the next big danger for body image?
Yahoo